Skip to main content
SpringerLink
Log in

Biological Links between Cannabinoids and HIV Infection

  • Chapter
Infectious Diseases and Substance Abuse

Part of the book series: Infectious Agents and Pathogenesis ((IAPA))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Feng, Y., Broder, C. C., Kennedy, P. E., and Berger, E. A. (1996). HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872–877.

    PubMed  CAS  Google Scholar 

  2. Peterson, P. K., Gekker, G., Chao, C. C., Hu, S., Edelman, C., Balfour, H. H. Jr. et al. (1992). Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-a-mediated mechanism. J. Clin. Invest. 89:574–580.

    PubMed  CAS  Google Scholar 

  3. Strathdee, S. A., Hoggs, R. S., O’Shaughnessy, M. V., Montaner, J. S., and Schechter, M. T. (1996). A decade of research on the natural history of HIV infection: Part 2. Cofactors. Clin. Invest. Med. 19:121–130.

    PubMed  CAS  Google Scholar 

  4. Timbo, B. B. and Tollefson, L. (1994). Nutrition: A cofactor in HIV disease. J. Am. Diabet. Assoc. 94:1018–1022.

    Article  CAS  Google Scholar 

  5. Whalen, C., Horsburgh, C. R., Hom, D., Lahart, C., Simberkoff, M., and Ellner, J. (1995). Accelerated course of human immunodeficiency virus infection after tuberculosis. Am. J. Respir. Crit. Care Med. 151:129–135.

    PubMed  CAS  Google Scholar 

  6. Baldwin, G. C., Roth, M. D., and Tashkin, D. P. (1998). Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J. Neuroimmunol. 83:133–138.

    Article  PubMed  CAS  Google Scholar 

  7. Dingle, G. A. and Oei, T. P. (1997). Is alcohol a cofactor of HIV and AIDS? Evidence from immunological and behavioral studies. Psychol. Bull. 122:56–71.

    Article  PubMed  CAS  Google Scholar 

  8. Donahoe, R. M. and Vlahov, D. (1998). Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J. Neuroimmunol. 8:77–87.

    Article  Google Scholar 

  9. Newell, G. R., Mansell, P. W., Wilson, M. B., Lynch, H. K., Spitz, M. R., and Hersh, E. M. (1985). Risk factor analysis among men referred for possible acquired immune deficiency syndrome. Prev. Med. 14:81–91.

    Article  PubMed  CAS  Google Scholar 

  10. Soderberg, L. S. (1998). Immunomodulation by nitrite inhalants may predispose abusers to AIDS and Kaposi’s Sarcoma. J. Neuroimmunol. 83:157–161.

    Article  PubMed  CAS  Google Scholar 

  11. Tindall, B., Philpot, C. R., Cooper, D. A., Gold, J., Donovan, B., Penny, R. et al. (1988). The Sydney AIDS project: Development of acquired immunodeficiency syndrome in a group of HIV seropositive homosexual men. Aust. NZ J. Med. 18:8–15.

    CAS  Google Scholar 

  12. Wang, Y. and Watson, R. R. (1995). Is alcohol consumption a cofactor in the development of acquired immunodeficiency syndrome? Alcohol 12:105–109.

    Article  PubMed  Google Scholar 

  13. Rasch, R. F., Weisen, C. A., MacDonald, B., Wechsberg, W. M., Perritt, R., and Dennis, M. L. (2000). Patterns of HIV risk and alcohol use among African-American crack abusers. Drug Alcohol Depend. 58:259–266.

    Article  PubMed  CAS  Google Scholar 

  14. Wang, M. Q., Collins, C. B., Kohler, C. L., DiClemente, R. J., and Wingood, G. (2000). Drug use and HIV risk-related sex behaviors: A street outreach study of black adults. South Med. J. 9:186–190.

    Google Scholar 

  15. Klein, T. W., Newton, C. A., Nakachi, N., and Friedman, H. (2000). Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta2 responses to Legionella pneumophila infection. J. Immunol. 164:6461–6466.

    PubMed  CAS  Google Scholar 

  16. Klein, T. W., Lane, B., Newton, C. A., and Friedman, H. (2000). The cannabinoid system and cytokine network. Proc. Soc. Exp. Med. Biol. 225:1–8.

    Article  CAS  Google Scholar 

  17. Pillai, R., Nair, B. S., and Watson, R. R. (1991). AIDS, drugs of abuse and the immune system: A complex immunotoxicological network. Arch. Toxicol. 65:609–617.

    Article  PubMed  CAS  Google Scholar 

  18. Peterson, P. K., Gekker, G., Chao, C. C., Schut, R., Molitor, T. W., and Balfour, H. H., Jr. (1991). Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor beta. J. Immunol. 146:81–84.

    PubMed  CAS  Google Scholar 

  19. Roth, M. D., Tashkin, D. P., Choi, R., Jamieson, D. D., Zack, J. A., and Baldwin, G. C. (2002). Cocaine enhances HIV replication in a HuPBL-SCID mouse model. J. Infect. Dis. 185:701–705.

    Article  PubMed  CAS  Google Scholar 

  20. Roth, M. D., Baldwin, G. C., and Tashkin, D. P. (2002). Effects of delta-9-tetrahydrocannabinol on human immune function and host defense. Chem. Phys. Lipids 121:229–239.

    Article  PubMed  CAS  Google Scholar 

  21. Weber, A. E., Chan, K., George, C., Hogg, R. S., Remis, R. S., Martindale, S. et al. (2001). Risk factors associated with HIV infection among young gay and bisexual men in Canada. J. Acquir. Immune Defic. Syndr. 28:81–88.

    PubMed  CAS  Google Scholar 

  22. Beal, J. E., Olson, R., Lefkowitz, L., Laubenstein, L., Bellman, P., Yangco, B. et al. (1997). Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J. Pain. Symptom Manage. 14:7–14.

    Article  PubMed  CAS  Google Scholar 

  23. Bredt, B. M., Higuera-Alhino, D., Shade, S. B., Hebert, S. J., McCune, J. M., and Abrams, D. I. (2002). Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients. J. Clin. Pharmacol. 42(Suppl):82S–89S.

    PubMed  CAS  Google Scholar 

  24. Caiaffa, W. T., Vlahov, D., Graham, N. M. H., Astemborski, J., Solomon, L., Nelson, K. E. et al. (1994). Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am. J. Respir. Crit. Care Med. 150:1493–1498.

    PubMed  CAS  Google Scholar 

  25. Esposito, G., Ligresti, A., Izzo, A. A., Bisogno, T., Ruvo, M., Di Rosa, M., et al. (2002). The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity. Mechanism and regulation. J. Biol. Chem. 277:50348–50354.

    Article  PubMed  CAS  Google Scholar 

  26. Klegeris, A., Bissonnette, C. J., and McGeer, P. L. (2003). Reduction of human monocyte cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br. J. Pharmacol. 139:775–786.

    Article  PubMed  CAS  Google Scholar 

  27. Torre, D., Pugliese, A., and Speranza, F. (2002). Role of nitric oxide in HIV-1 infection: Friend or foe? Lancet Infect. Dis. 2:273–280.

    Article  PubMed  CAS  Google Scholar 

  28. Harvey, D. J. (1984). Chemistry, metabolism, and pharmacokinetics of the cannabinoids. In G. G. Nahas (ed.), Marijuana in Science and Medicine, Raven Press, New York, pp. 37–107.

    Google Scholar 

  29. Novotny, M., Merli, F., Weisler, D., Fencl, M., and Saeed, T. (1982). Fractionation and capillary gas chromatographic-mass spectrometric characterization of the neutral components in marijuana and tobacco smoke condensates. J. Chomatogr. 238:141–150.

    Article  CAS  Google Scholar 

  30. Roth, M. D., Marquez-Magallanes, J. A., Yuan, M., Sun, W., Tashkin, D. P., and Hankinson, O. (2001). Induction and regulation of the carcinogen-metabolizing enzyme, CYP1A1, by marijuana smoke and Δ9-Tetrahydrocannabinol. Am. J. Respir. Cell Mol. Biol. 24:1–6.

    Google Scholar 

  31. Gaoni, Y. and Mechoulam, R. (1964). Hashish III: Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86:1646–1647.

    Article  CAS  Google Scholar 

  32. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G. et al. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946–1949.

    PubMed  CAS  Google Scholar 

  33. Di Marzo, V., Bisogno, T., De Petrocellis, L., Melck, D., and Martin, B. R. (1999). Cannabimimetic fatty acid derivatives: The anandamide family and other endocannabinoids. Curr. Med. Chem. 6:721–744.

    PubMed  Google Scholar 

  34. Hanus, L., Abu-Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E. et al. (2001). 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc. Natl. Acad. Sci. USA 98:3662–3665.

    Article  PubMed  CAS  Google Scholar 

  35. Lee, M., Yang, K. H., and Kaminski, N. E. (1995). Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J. Pharmacol. Exp. Ther. 275:529–536.

    PubMed  CAS  Google Scholar 

  36. Gerard, C. M., Mollereau, C., Vassart, G., and Parmentier, M. (1991). Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279:129–134.

    PubMed  CAS  Google Scholar 

  37. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., and Bonner, T. I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561–564.

    Article  PubMed  CAS  Google Scholar 

  38. Bouaboula, M., Rinaldi, M., Carayon, P., Carillon, C., Delpech, B., Shire, D. et al. (1993). Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214:173–180.

    Article  PubMed  CAS  Google Scholar 

  39. Galiegue, S., Mary, S., Marchand, J., Dussossoy, D., Carriere, D., Carayon, P. et al. (1995). Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232:54–61.

    Article  PubMed  CAS  Google Scholar 

  40. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J. F., Beslot, F. et al. (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283:401–404.

    Article  PubMed  CAS  Google Scholar 

  41. Huestis, M. A., Gorelick, D. A., Heishman, S. J., Preston, K. L., Nelson, R. A., Moolchan, E. T. et al. (2001). Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch. Gen. Psychiatry 58:322–328.

    Article  PubMed  CAS  Google Scholar 

  42. Munro, S., Thomas, K. L., and Abu-Shaar, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61–65.

    Article  PubMed  CAS  Google Scholar 

  43. Nong, L., Newton, C., Cheng, Q., Friedman, H., Roth, M. D., and Klein, T. W. (2002). Altered cannabinoid receptor mRNA expression in peripheral blood mononuclear cells from marijuana smokers. J. Neuroimmunol. 127:169–176.

    Article  PubMed  CAS  Google Scholar 

  44. Marchand, J., Bord, A., Penarier, G., Laure, F., Carayon, P., and Casellas, P. (1999). Quantitative method to determine mRNA levels by reverse transcriptase-polymerase chain reaction from leukocyte subsets purified by fluorescence-activated cell sorting: Application to peripheral cannabinoid receptors. Cytometry 35:227–234.

    Article  PubMed  CAS  Google Scholar 

  45. Howlett, A. C. (1995). Pharmacology of cannabinoid receptors. Ann. Rev. Pharmacol. Toxicol. 35:607–634.

    Article  CAS  Google Scholar 

  46. Berdyshev, E. V. (2000). Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids 108:169–190.

    Article  PubMed  CAS  Google Scholar 

  47. Kaminski, N. E. (1998). Regulation of the cAMP cascade, gene expression and immune function by cannabinoid receptors. J. Neuroimmunol. 83:124–132.

    Article  PubMed  CAS  Google Scholar 

  48. Fride, E. (2002). Endocannabinoids in the central nervous system—an overview. Prostaglandins Leukot. Essent. Fatty Acids 66:221–233.

    Article  PubMed  CAS  Google Scholar 

  49. Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A. et al. (2002). International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54:161–202.

    Article  PubMed  CAS  Google Scholar 

  50. Klein, T. W., Newton, C., and Friedman, H. (1998). Cannabinoid receptors and immunity. Immunol. Today 19:373–381.

    Article  PubMed  CAS  Google Scholar 

  51. Palmer S. L., Thakur, G. A., and Makriyannis, A. (2002). Cannabinergic ligands. Chem. Phys. Lipids 121:3–19.

    Article  PubMed  CAS  Google Scholar 

  52. Breen, E. C., Rezai, A. R., Nakajima, K., Hirano, T., Beall, G. N., Mitsuyasu, R. T. et al. (1990). Elevated levels of interleukin 6 (IL-6) are associated with human immunodeficiency virus (HIV) infection. J. Immunol. 144:480–484.

    PubMed  CAS  Google Scholar 

  53. Odeh, M. (1990). The role of tumour necrosis factor-alpha in acquired immunodeficiency syndrome. J. Intern. Med. 228:549–556.

    Article  PubMed  CAS  Google Scholar 

  54. Breen, E. C. (2002). Pro-and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome. Pharmacol. Ther. 95:295–304.

    Article  PubMed  CAS  Google Scholar 

  55. Clerici, M., Wynn, T. A., Berzofsky, J. A., Blatt, S. P., Hendrix, C. W., Sher, A. et al. (1994). Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 93:768–775.

    PubMed  CAS  Google Scholar 

  56. Kekow, J., Wachsman, W., McCutchan, J. A., Cronin, M., Carson, D. A., and Lotz, M. (1990). Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 87:8321–8325.

    PubMed  CAS  Google Scholar 

  57. Lane, H. C., Masur, H., Edgar, L. C., Whalen, G., Rook, A. H., and Fauci, A. S. (1983). Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309:453–458.

    Article  PubMed  CAS  Google Scholar 

  58. Chehimi, J., Starr, S. E., Frank, I., D’Andrea, A., Ma, X., MacGregor, R. R. et al. (1994). Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361–1366.

    Article  PubMed  CAS  Google Scholar 

  59. Ma, X. and Montaner, L. J. (2000). Proinflammatory response and IL-12 expression in HIV-1 infection. J. Leukoc. Biol. 68:383–390.

    PubMed  CAS  Google Scholar 

  60. Broder, C. C. and Collman, R. G. (1997). Chemokine receptors and HIV. J. Leukoc. Biol. 62:20–29.

    PubMed  CAS  Google Scholar 

  61. Kitchen, S., Korin, Y., Roth, M. D., Landay, A., and Zack, J. A. (1998). Costimulation of naive CD8+ lymphocytes induces CD4 expression and allows HIV-1 infection. J. Virol. 72:9054–9060.

    PubMed  CAS  Google Scholar 

  62. Steinman, R. M., Granelli-Piperno, A., Pope, M., Trumpfheller, C., Ignatius, R., Arrode, G. et al. (2003). The interaction of immunodeficiency viruses with dendritic cells. Curr. Top. Microbiol. Immunol. 276:1–30.

    PubMed  CAS  Google Scholar 

  63. Weissman, D. and Fauci, A. S. (1997). Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection. Clin. Microbiol. Rev. 10:358–367.

    PubMed  CAS  Google Scholar 

  64. Ruegg, C. L. and Engleman, E. C. (1990). Impaired immunity in AIDS. The mechanisms responsible and the potential reversal by antiviral therapy. Ann NY Acad. Sci. 616:307–317.

    PubMed  CAS  Google Scholar 

  65. Cabral, G. A. and Dove Pettit, D. A. (1998). Drugs and immunity: Cannabinoids and their role in decreased resistance to infectious disease. J. Neuroimmunol. 83:116–123.

    Article  PubMed  CAS  Google Scholar 

  66. Klein, T. W., Newton, C. A., Larson, K., Lu, L., Perkins, I., Nong, L. et al. (2003). The cannabinoid system and immune modulation. J. Leukoc. Biol. 74:486–496.

    Article  PubMed  CAS  Google Scholar 

  67. Salzet, M., Breton, C., Bisogno, T., and Di Marzo, V. (2000). Comparative biology of the endocannabinoid system possible role in the immune response. Eur. J. Biochem. 267:4917–4927.

    Article  PubMed  CAS  Google Scholar 

  68. Nahas, G. G., Zagury, D., Schwartz, I. W., and Nagel, M. D. (1973). Evidence for the possible immunogenicity of delta 9-tetrahydrocannabinol (THC) in rodents. Nature 243:407–408.

    Article  PubMed  CAS  Google Scholar 

  69. Nahas, G. G., Suciu-Foca, N., Armand, J.-P., and Morishima, A. (1974). Inhibition of cellular mediated immunity in marijuana smokers. Science 183:419–420.

    PubMed  CAS  Google Scholar 

  70. Newton, C. A., Klein, T. W., and Friedman, H. (1994). Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect. Immun. 62:4015–4020.

    PubMed  CAS  Google Scholar 

  71. Zhu, L. X., Sharma, S., Stolina, M., Gardner, B., Roth, M. D., Tashkin, D. P. et al. (2000). Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J. Immunol. 165:373–380.

    PubMed  CAS  Google Scholar 

  72. Mosmann, T. R. and Moore, K. W. (1991). The role of IL-10 in cross-regulation of TH1 and TH2 responses. Immunol. Today 12:A49–A53.

    Article  PubMed  CAS  Google Scholar 

  73. Huang, M., Wang, J., Lee, P., Sharma, S., Mao, J. T., Meissner, H. et al. (1995). Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res. 55:3847–3853.

    PubMed  CAS  Google Scholar 

  74. Sogn, J. A. (1998). Tumor immunology: The glass is half full. Immunity 9:757–763.

    Article  PubMed  CAS  Google Scholar 

  75. Gardner, B., Zhu, L. X., Sharma, S., Liu, Q., Makriyannis, A., Tashkin, D. P. et al. (2002). Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-β. Biochem. Biophys. Res. Commun. 290:91–96.

    Article  PubMed  CAS  Google Scholar 

  76. Yuan, M., Kiertscher, S. M., Cheng, Q., Zoumalan, R., Tashkin, D. P., and Roth, M. D. (2002). Δ9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T-cells. J. Neuroimmunol. 133:124–131.

    Article  PubMed  CAS  Google Scholar 

  77. Fischer-Stenger, K., Dove Pettit, D. A., and Cabral, G. A. (1993). Δ9-Tetrahydrocannabinol inhibition of tumor necrosis factor-α suppression of post-translational events. J. Pharmacol. Exp. Ther. 267:1558–1565.

    PubMed  CAS  Google Scholar 

  78. Klein, T. W., Newton, C., Widen, R., and Friedman, H. (1993). Δ9-Tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila. J. Pharmacol. Exp. Ther. 267:635–640.

    PubMed  CAS  Google Scholar 

  79. Zhu, W., Newton, C., Daaka, Y., Friedman, H., and Klein, T. W. (1994). Δ9-Tetrahydrocannabinol enhances the secretion of interleukin-1 from endotoxinstimulated macrophage. J. Pharmacol. Exp. Ther. 270:1334–1339.

    PubMed  CAS  Google Scholar 

  80. Carayon, P., Marchand, J., Dussossoy, D., Derocq, J. M., Jbilo, O., Bord, A. et al. (1998). Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. Blood 92:3605–3615.

    PubMed  CAS  Google Scholar 

  81. Schatz, A. R., Koh, W. S., and Kaminski, N. E. (1993). Delta 9-tetrahydrocannabinol selectively inhibits T-cell dependent human immune responses through direct inhibition of accessory cell function. Immunopharmacology 26:129–137.

    Article  PubMed  CAS  Google Scholar 

  82. McKallip, R. J., Lombard, C., Fisher, M., Martin, B. R., Ryu, S., Grant, S. et al. (2002). Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 100:627–634.

    Article  PubMed  CAS  Google Scholar 

  83. Schwarz, H., Blanco, F. J., and Lotz, M. (1994). Anandamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J. Neuroimmunol. 55:107–115.

    Article  PubMed  CAS  Google Scholar 

  84. Zhu, W., Friedman, H., and Klein, T. W. (1998). Delta 9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: Involvement of Bcl-2 and caspase-1. J. Pharmacol. Exp. Ther. 286:1103–1109.

    PubMed  CAS  Google Scholar 

  85. Bennasser, Y. and Bahraoui, E. (2002). HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: Involvement of protein kinase C-betaII and-delta. FASEB J. 16:546–554.

    Article  PubMed  CAS  Google Scholar 

  86. Rasty, S., Thatikunta, P., Gordon, J., Khalili, K., Amini, S., and Glorioso, J. C. (1996). Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression. Proc. Natl. Acad. Sci. USA 93:6073–6078.

    Article  PubMed  CAS  Google Scholar 

  87. Taoufik, Y., Lantz, O., Wallon, C., Charles, A., Dussaix, E., and Delfraissy, J. F. (1997). Human immunodeficiency virus gp120 inhibits interleukin-12 secretion by human monocytes: An indirect interleukin-10-mediated effect. Blood 89:2842–2848.

    PubMed  CAS  Google Scholar 

  88. Wang, J., Guan, E., Roderiquez, G., and Norcross, M. A. (2001). Synergistic induction of apoptosis in primary CD4(+) T cells by macrophage-tropic HIV-1 and TGF-beta1. J. Immunol. 167:3360–3366.

    PubMed  CAS  Google Scholar 

  89. Bodi, I., Kimmel, P. L., Abraham, A. A., Svetkey, L. P., Klotman, P. E., and Kopp, J. B. (1997). Renal TGF-beta in HIV-associated kidney diseases. Kidney Int. 51:1568–1577.

    PubMed  CAS  Google Scholar 

  90. Lima, R. G., Van Weyenbergh, J., Saraiva, E. M., Barral-Netto, M., Galvao-Castro, B., and Bou-Habib, D. C. (2002). The replication of human immunodeficiency virus type 1 in macrophages is enhanced after phagocytosis of apoptotic cells. J. Infect. Dis. 185:1561–1566.

    Article  PubMed  Google Scholar 

  91. Lotz, M. and Seth, P. (1993). TGF beta and HIV infection. Ann. NY Acad Sci. 685:501–511.

    PubMed  CAS  Google Scholar 

  92. McKallip, R. J., Lombard, C., Martin, B. R., Nagarkatti, M., and Nagarkatti, P. S. (2002). Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo. Blood 100:627–634.

    Article  PubMed  CAS  Google Scholar 

  93. Ancuta, P., Bakri, Y., Chomont, N., Hocini, H., Gabuzda, D., and Haeffner-Cavaillon, N. (2001). Opposite effects of IL-10 on the ability of dendritic cells and macrophages to replicate primary CXCR4-dependent HIV-1 strains. J. Immunol. 166:4244–4253.

    PubMed  CAS  Google Scholar 

  94. Houle, M., Thivierge, M., Le Gouill, C., Stankova, J., and Rola-Pleszczynski, M. (1999). IL-10 up-regulates CCR5 gene expression in human monocytes. Inflammation 23:241–251.

    PubMed  CAS  Google Scholar 

  95. Weissman, D., Poli, G., and Fauci, A. S. (1995). IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9:442–449.

    PubMed  CAS  Google Scholar 

  96. Baronzio, G., Zambelli, A., Comi, D., Barlocco, A., Baronzio, A., Marchesi, P. et al. (1999). Proinflammatory and regulatory cytokine levels in AIDS cachexia. In Vivo, 13:499–502.

    PubMed  CAS  Google Scholar 

  97. Jimenez, J. L., Gonzalez-Nicolas, J., Alvarez, S., Fresno, M., and Munoz-Fernandez, M. A. (2001). Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide. J. Virol. 75:4655–4663.

    Article  PubMed  CAS  Google Scholar 

  98. Brendt, D. S. and Snyder, S. H. (1994). Nitric oxide: A physiologic messenger molecule. Ann. Rev. Biochem. 63:175–195.

    Article  Google Scholar 

  99. Mayer, B. (2000). Nitric oxide. In B. Mayer, P. Cuatrecasas, K. Starke, G. V. Born, and P. Taylor (eds), Handbook of Experimental Pharmacology, Volume: Nitric Oxide, Springer-Verlag, New York, pp. 1–667.

    Google Scholar 

  100. Moncada, S., Palmer, R. M., and Higgs, E. A. (1991). Nitric oxide physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109–142.

    PubMed  CAS  Google Scholar 

  101. Bogdan, C. (2000). The function of nitric oxide in the immune system. In B. Mayer, P. Cuatrecasas, K. Starke, G. V. Born, and P. Taylor (eds), Handbook of Experimental Pharmacology, Volume: Nitric Oxide, Springer-Verlag, New York, pp. 443–492.

    Google Scholar 

  102. Bogdan, C. (2001). Nitric oxide and the immune response. Nat. Immunol. 2:907–916.

    Article  PubMed  CAS  Google Scholar 

  103. Chang, Y.-H., Lee, S. T., and Lin, W.-W. (2001). Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: Involvement of eicosanoids. J. Cell. Biochem. 81:715–723.

    Article  PubMed  CAS  Google Scholar 

  104. Stuehr, D. J. and Marletta, M. A. (1987). Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-γ. J. Immunol. 139:518–525.

    PubMed  CAS  Google Scholar 

  105. Akarid, K., Sinet, M., Desforges, B., and Gougerot-Pocidalo, M. A. (1995). Inhibitory effect of nitric oxide on the replication of murine retrovirus in vitro and in vivo. J. Virol. 69:7001–7005.

    PubMed  CAS  Google Scholar 

  106. Croen, K. D. (1993). Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91:2446–2452.

    Article  PubMed  CAS  Google Scholar 

  107. Karupiah, G., Xie, Q., Buller, R. M. L., Nathan, C., Duarte, C., and MacMicking, J. D. (1993). Inhibition of viral replication by interferon-gamma induced nitric oxide synthase. Science 61:1445–1448.

    Google Scholar 

  108. Mannick, J. B. (1995). The antiviral role of nitric oxide. Res. Immunol. 146:693–697.

    Article  PubMed  CAS  Google Scholar 

  109. Blond, D., Cheret, A., Raoul, H., LeGrand, R., Caufour, P., Theodoro, F. et al. (1998). Nitric oxide synthesis during acute SIV mac251 infection of macaques. Res. Virol. 149:75–86.

    Article  PubMed  CAS  Google Scholar 

  110. Groeneveld, P. H., Kroon, F. P., Nibbering, P. H., Bruisten, S. M., van Swieten, P., and van Furth, R. (1996). Increased production of nitric oxide correlates with viral load and activation of mononuclear phagocytes in HIV-infected patients. Scand. J. Infect. Dis. 28:341–345.

    PubMed  CAS  Google Scholar 

  111. Zangerle, R., Fuchs, D., Reinegger, G., Werner-Felmayer, G., Gallati, H., Wachter, H. et al. (1995). Serum nitrite and nitrate in infection with human immunodeficiency virus type-1. Immunobiology 193:59–70.

    PubMed  CAS  Google Scholar 

  112. Zhao, M.-L., Kim, M.-O., Morgello, S., and Lee, S. C. (2001). Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis. J. Neuroimmun. 115:182–191.

    Article  CAS  Google Scholar 

  113. Chen, F., Lu, Y., Castranova, V., Rojanasakul, Y., Miyahare, K., Shizuta, Y. et al. (1999). Nitric oxide inhibits HIV tat-induced NFκB activation. Am. J. Pathol. 155:275–284.

    PubMed  CAS  Google Scholar 

  114. Mannick, J. B., Stamler, J. S., Teng, E., Simpson, N., Lawrence, J., Jordan, J. et al. (1999). Nitric oxide modulates HIV-1 replication. J. Acquir. Immune. Defic. Syndr. 22:1–9.

    PubMed  CAS  Google Scholar 

  115. Persichini, T., Colasanti, M., Lauro, G. M., and Ascenzi, P. (1998). Cysteine nitrosylation inactivates the HIV-1 protease. Biochem. Biophys. Res. Commun. 250:575–576.

    Article  PubMed  CAS  Google Scholar 

  116. Persichini, T., Colasanti, M., Fraziano, M., Colizzi, V., Ascenzi, P., and Lauro, G. M. (1999). Nitric oxide inhibits HIV-replication in human astrocytoma cells. Biochem. Biophys. Res. Commun. 254:200–202.

    Article  PubMed  CAS  Google Scholar 

  117. Persichini, T., Colasanti, M., Fraziano, M., Colizzi, V., Medana, C., Polticelli, F. et al. (1999). Nitric oxide inhibits the HIV-1 reverse transcriptase activity. Biochem. Biophys. Res. Commun. 258:624–627.

    Article  PubMed  CAS  Google Scholar 

  118. Sekkai, D., Aillet, F., Israel, N., and Lepoivre, M. (1998). Inhibition of NF-κB and HIV-1 long terminal repeat transcriptional activation by inducible nitric oxide synthase 2 activity. J. Biol. Chem. 273:3895–3900.

    Article  PubMed  CAS  Google Scholar 

  119. Fehsel, K., Kroncke, K. D., Meyer, K. L., Huber, H., Wahn, V., and Kolb-Bachofen, V. (1995). Nitric oxide induces apoptosis in mouse thymocytes. J. Immunol. 155: 2858–2865.

    PubMed  CAS  Google Scholar 

  120. Mossalayi, M. D., Becherel, P. A., and Debre, P. (1999). Critical role of nitric oxide during apoptosis of peripheral blood leukocytes from patients with AIDS. Mol. Med. 5:812–819.

    PubMed  CAS  Google Scholar 

  121. Taylor-Robinson, A. W. (1997). Inhibition of IL-2 production by nitric oxide: A novel self-regulatory mechanism for Th1 proliferation. Immunol. Cell. Biol. 75:167–175.

    PubMed  CAS  Google Scholar 

  122. Torre, D. and Ferrario, G. (1996). Immunological aspects of nitric oxide in HIV-1 infection. Med. Hypotheses 47:405–407.

    Article  PubMed  CAS  Google Scholar 

  123. Coffey, R. G., Snella, E., Johnson, K., and Pross, S. (1996). Inhibition of macrophage nitric oxide production by tetrahydrocannabinol in vivo and in vitro. Int. J. Immunopharmacol. 18:749–752.

    Article  PubMed  CAS  Google Scholar 

  124. Coffey, R. G., Yamamoto, Y., Snella, E., and Pross, S. (1996). Tetrahydrocannabinol inhibition of macrophage nitric oxide production. Biochem. Pharm. 52:743–751.

    Article  PubMed  CAS  Google Scholar 

  125. Jeon, Y., Yang, K. H., Pulaski, J. T., and Kaminski, N. E. (1996). Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-kappa B/Rel activation. Mol. Pharmacol. 50:334–341.

    PubMed  CAS  Google Scholar 

  126. Molina-Holgado, F., Molina-Holgado, E., Guaza, C., and Rothwell, N. J. (2002). Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. J. Neurosci. Res. 67:829–836.

    Article  PubMed  CAS  Google Scholar 

  127. Albina, J. E. (1995). On the expression of nitric oxide synthase by human macrophages. Why no NO? J. Leukoc. Biol. 58:643–649.

    PubMed  CAS  Google Scholar 

  128. Denis, M. (1994). Human monocytes/macrophages: NO or no NO? J. Leukoc. Biol. 55:682–684.

    PubMed  CAS  Google Scholar 

  129. Zhang, X., Laubach, V. E., Alley, E. W., Edwards, K. A., Sherman, P. A., Russell, S. W. et al. (1996). Transcriptional basis for hyporesponsiveness of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-gamma. J. Leukoc. Biol. 59:575–585.

    PubMed  CAS  Google Scholar 

  130. Nicholson, S., Bonecini-Almeida Mda, G., Lapa e Silva, J. R., Nathan, C., Xie, Q. W., Mumford, R. et al. (1996). Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183:2293–2302.

    Article  PubMed  CAS  Google Scholar 

  131. Nozaki, Y., Hasegawa, Y., Ichiyama, S., Nakashima, I., and Shimokata, K. (1997). Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect. Immun. 65:3644–3647.

    PubMed  CAS  Google Scholar 

  132. Wang, C. H., Liu, C. Y., Lin, H. C., Yu, C. T., Chung, K. F., and Kuo, H. P. (1998). Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur. Respir. J. 11:809–815.

    Article  PubMed  CAS  Google Scholar 

  133. Shay, A. H., Choi, R., Whittaker, K., Salehi, K., Kitchen, C. M. R., Tashkin, D. P. et al. (2003). Impairment of antimicrobial activity and nitric oxide production in alveolar macrophages from smokers of marijuana and cocaine. J. Infect. Dis. 187:700–704

    Article  PubMed  CAS  Google Scholar 

  134. Baldwin, G. C., Tashkin, D. P., Buckley, D. M., Park, A. N., Dubinett, S. M., and Roth, M. D. (1997). Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am. J. Respir. Crit. Care Med. 156:1606–1613.

    PubMed  CAS  Google Scholar 

  135. Boven, L. A., Gomes, L., Hery, C., Gray, F., Verhoef, J., Portegies, P. et al. (1999). Increased peroxynitrite activity in AIDS dementia complex: Implications for the neuropathogenesis of HIV-1 infection. J. Immunol. 162:4319–4327.

    PubMed  CAS  Google Scholar 

  136. Richman, D. D. (2001). HIV chemotherapy. Nature 410:995–1001.

    Article  PubMed  CAS  Google Scholar 

  137. Mosier, D. E., Gulizia, R. J., Baird, S. M., and Wilson, D. B. (1988). Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256–259.

    Article  PubMed  CAS  Google Scholar 

  138. Jamieson, B. D. and Zack, J. A. (1998). In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus. J. Virol. 72:6520–6526.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095

    Gayle C. Baldwin

  2. Division of Pulmonary and Critical Care, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095-1690

    Michael D. Roth

Authors
  1. Gayle C. Baldwin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael D. Roth
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medical Microbiology and Immunology, University of South Florida College of Medicine, Tampa, FL

    Herman Friedman  & Thomas W. Klein  & 

  2. Department of Experimental Pathology, University of Pisa, Pisa, Italy

    Mauro Bendinelli

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Baldwin, G.C., Roth, M.D. (2005). Biological Links between Cannabinoids and HIV Infection. In: Friedman, H., Klein, T.W., Bendinelli, M. (eds) Infectious Diseases and Substance Abuse. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-306-48688-1_2

Download citation

Publish with us

Policies and ethics

Search

Navigation